ARCHIVES

Rescission Cuts $5-6 Mil. From NCI FY94 Appropriations , Affects Intramural Program

This article is from The Cancer Letter archive.

Vol. 20 No. 10 | March 11, 1994

Download PDF Visit The Full Archive

Related Articles

ODAC Votes For Accelerated Approval For Adcetris For Two Lymphoma Indications

July 22, 2011

Eight States Get Cervical Cancer Screening Planning Contracts

June 21, 1974

Practice of Oncology Must Incorporate Clinical Research, NCI Director Tells ASCO

May 30, 1997

NCI to Host SBIR Investor Forum

November 7, 2014

Ethics Commission Say HHS Should Test Injury Compensation

June 18, 1982

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

November 28, 2014